Search Results for "Clonazepam Paroxetine"
Original Source: Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
The purpose of this study is to examine the safety and effectiveness of the drug combination paroxetine and clonazepam in treating people with panic disorder (PD) and major depression. The main goal in treating people with PD is to rapidly reduce symptom severity and improve functioning. While numerous drug therapies have been used to treat PD, these treatments are limited by variable response rates and suboptimal side effect profiles. Evidence suggests that clonazepam given w...
Matching Channels
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of e...
Trigeminal Neuralgia (TN) is an extremely severe facial pain that tends to come and go unpredictably in sudden shock-like attacks. The pain is often described as stabbing, shooting, excruciating, bu...
Matching News
Paroxetine could treat vascular complications of diabetes
University of Texas Medical Branch at Galveston researchers have discovered that the commonly used antidepressant drug paroxetine could also become a therapy for the vascular complications of diabetes...
FDA committee to discuss low-dose paroxetine mesylate, Serada
FDA's Advisory Committee for Reproductive Health Drugs will meet on March 4 to discuss an NDA from Noven Pharmaceuticals Inc. for low-dose paroxetine mesylate and an NDA from Depomed Inc. (NASDAQ:DEPO...
Antidepressant Drug Paroxetine Could Double As Diabetes Drug
Lee Rannals for redOrbit.com – Your Universe Online Researchers have found the commonly used antidepressant drug paroxetine could become a therapy for the vascular complications of diabetes. The s...
Replace clonazepam with an alternative antiepileptic drug to reduce drug misuse
As a group of GPs who work in a women’s prison we welcome the series on prison medicine.1 We want to raise a matter that has profound implications for prison care and for primary care prescribing—...
FDA panel rebuffs two menopause compounds
FDA's Reproductive Health Drugs Advisory Committee voted on Monday that the overall benefit/risk profiles of two compounds do not support approval to treat moderate to severe vasomotor symptoms (VMS)...
Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission
Haploinsufficiency of the gene SCN1A (SCN1A+/−) causes Dravet’s syndrome in humans, a form of epilepsy with autistic features; this paper shows that Scn1a+/− mice have the same symptoms, and tha...
GSK accused of “market abuse” by UK Office of Fair Trading
The UK’s Office of Fair Trading (OFT) has issued a Statement of Objections to a number of pharmaceutical companies alleging they acted to delay effective competition in the UK supply of antidepressa...
Paroxetine as Inhibitor of Diabetic Endothelial Dysfunction
Can this antidepressant reduce cardiovascular risk associated with diabetes? Diabetes
Matching PubMed Articles
Pancytopenia associated with clonazepam.
ABSTRACT: We report a case of a 48-year-old Chinese female with end-stage renal disease and chronic anemia on hemodialysis. Clonazepam was prescribed for myoclonus disorder two weeks prior to her hosp...
Selective serotonin reuptake inhibitors (SSRIs) are widely used to treat both anxiety disorders and depressive disorders. However, nonadherence to SSRIs is a major issue in recurrence. In the present...
Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
Discontinuation symptoms can follow the stoppage of almost all classes of antidepressants, including selective serotonin reuptake inhibitors. We report two cases suffering from visual and auditory hal...
Therapeutic Drug Monitoring of Clonazepam.
Clonazepam is a 1-4 benzodiazepine mainly used to treat epilepsy and epileptiform convulsion state. Rapidly absorbed after oral administration, it is widely distributed in the organism and is extensiv...
Paroxetine increases the levels of neurosteroids, such as allopregnanolone (AP), that influence the excitability of the central nervous system by positive allosteric modulation of γ-aminobutyric acid...
